Reaction

Dermal Cyst reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,423 reports · 40 co-occurring drugs

As of the last recalculation, Dermal Cyst appears in 2,423 FAERS reports alongside 40 co-occurring drug terms. The strongest observed disproportionality signal is DIMENHYDRINATE (PRR 17.1).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Dimenhydrinate	21	17.1	17.1
Vemurafenib	20	14.4	14.4
Diphenhydramine Hydrochloride Capsule, Liquid Filled	25	10.1	10.2
Mupirocin	14	9.0	9.0
Mupirocin Calcium	14	8.8	8.8
Infliximab-Dyyb	29	8.6	8.6
Clindamycin	28	8.6	8.6
Clindamycin Phosphate	32	8.3	8.3
Tamsulosin Hydrochloride	18	7.6	7.6
Tizanidine	21	7.6	7.6
Carisoprodol	16	7.2	7.3
Cephalexin	18	7.2	7.2
Adalimumab	480	7.0	7.0
Psyllium Husk	8	7.0	7.0
Epoetin Alfa	9	6.5	6.6
Diltiazem Hydrochloride Extended-Release Tablets	8	6.1	6.1
Ketoconazole	12	6.0	6.0
Brinzolamide	6	5.9	5.9
Ketoconazole Foam	10	5.8	5.8
Doxycycline Hyclate	45	5.8	5.8
Ketoconazole Cream, 2%	10	5.8	5.8
Finasteride	39	5.6	5.6
Sulfur	5	5.1	5.1
Salicylic Acid	31	5.1	5.1
Triamcinolone Acetonide Ointment Usp, 0.05%	13	4.8	4.8
Upadacitinib	42	4.5	4.5
Isotretinoin	24	4.2	4.2
Adapalene	82	4.0	4.0
Etonogestrel And Ethinyl Estradiol	10	3.9	3.9
Testosterone Cypionate	4	3.9	3.9
Risankizumab-Rzaa	35	3.7	3.7
Loratadine And Pseudoephedrine Sulfate	3	3.2	3.2
Sevelamer Carbonate	4	3.0	3.0
Diroximel Fumarate	4	2.9	2.9
Conjugated Estrogens And Medroxyprogesterone Acetate	7	2.6	2.6
Paricalcitol	4	2.4	2.4
Minoxidil	10	1.9	1.9
Minoxidil Foam 5% (Womens)	7	1.8	1.8
Cinacalcet Hydrochloride	6	1.1	1.1
Levonorgestrel	22	0.9	0.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.